Priority Date: 17.08.10 (US 20100374555P)

RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

  • Application ID: EP11818592
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
4 offices
Technology Company
no operation time available
3 offices
active in Legal Services
Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This EP application has the IPC class C07 (ORGANIC CHEMISTRY) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Fry Heath & Spence LLP and Vossius & Partner Patentanwälte Rechtsanwälte mbB are specialized in the combination C07 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB, Isenbruck Bösl Hörschler LLP and 152 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 17.08.2010 - Priority Date (US 20100374555P)
  • 23.02.2012 - Publication A2 (WO2012024170)
  • 26.06.2013 - Publication A2 (EP2606134)

IPC Classification